Navigating next-gen cancer care: What new guidelines, treatments and trends mean for payers
Wednesday, September 17th, 2025 | 1:00 PM - 2:00 PM CT
The oncology landscape is shifting rapidly. With earlier-onset cancers on the rise, new therapies and evolving care models, payers must rethink traditional approaches to stay ahead of cost and complexity and better support their members.
Join us for a conversation with health plan leaders who bring deep expertise in oncology strategy and firsthand experience shaping innovative cancer care models that are driving meaningful results. They’ll share practical insights on what’s changing in oncology—and what payers need to do now to stay ahead.
Join us for a conversation with health plan leaders who bring deep expertise in oncology strategy and firsthand experience shaping innovative cancer care models that are driving meaningful results. They’ll share practical insights on what’s changing in oncology—and what payers need to do now to stay ahead.
Key takeaways:
- What shifting cancer guidelines, treatment advances and prior authorization reforms mean for utilization and access
- Steps to prepare for the long-term impact of rising early-onset cancer rates
- How forward looking payers are applying value-based models in oncology to improve member experience and outcomes
Presenters:
Lucy R. Langer, MD, MSHS
National Medical Director/CMO of Oncology, Genomics, and Laboratory, UnitedHealthcare
Ali Khan, MD, MPP, FACP
Vice President & Chief Medical Officer, Aetna Medicare
